Katalin Toth
Budapest, BU 1117, Hungary
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
CYP1A2 mRNA Expression Rather than Genetic Variants Indicate Hepatic CYP1A2 Activity.
Journal: Pharmaceutics
Published: January 14, 2022
Association of clozapine-related metabolic disturbances with CYP3A4 expression in patients with schizophrenia.
Journal: Scientific reports
Published: September 16, 2020
Clinical significance of personalized tacrolimus dosing by adjusting to donor CYP3A-status in liver transplant recipients.
Journal: British journal of clinical pharmacology
Published: May 14, 2020
End-stage renal disease reduces the expression of drug-metabolizing cytochrome P450s.
Journal: Pharmacological reports : PR
Published: December 16, 2019
Phenoconversion of CYP2D6 by inhibitors modifies aripiprazole exposure.
Journal: European archives of psychiatry and clinical neuroscience
Published: August 23, 2018
Combination of CYP2C19 genotype with non-genetic factors evoking phenoconversion improves phenotype prediction.
Journal: Pharmacological reports : PR
Published: October 10, 2017
Relevance of CYP2C9 Function in Valproate Therapy.
Journal: Current neuropharmacology
Published: May 17, 2017
Potential Role of Patients' CYP3A-Status in Clozapine Pharmacokinetics.
Journal: The international journal of neuropsychopharmacology
Published: December 13, 2016
Identification of 8-Hydroxyquinoline Derivatives Active Against Somatic V658F Mutant JAK1-Dependent Cells.
Journal: Archiv der Pharmazie
Published: August 25, 2016
Optimization of Clonazepam Therapy Adjusted to Patient's CYP3A Status and NAT2 Genotype.
Journal: The international journal of neuropsychopharmacology
Published: July 09, 2016
Last Updated: 09/26/2026